Technology • Enterprise AI Ontology & Defense Software • SIC 7372
$184.11 ▼ -12.31
(-6.27%)
MKT CAP: $446.32B • VOL: 26.96M
52W L $106 52W H $213
PLTR // SEC EDGAR XBRL STANDARDIZED FINANCIAL STATEMENTS (FA <GO>)
| LINE ITEM (USD / %) | FY 2025
FILED 2026-02-17 | FY 2024
FILED 2026-02-17 | FY 2023
FILED 2026-02-17 | FY 2022
FILED 2025-02-18 | FY 2021
FILED 2024-02-20 |
|---|---|---|---|---|---|
| Revenue (Total Sales) | $4.48B | $2.87B | $2.23B | $1.91B | $1.54B |
| YoY Revenue Growth % | +56.2% | +28.8% | +16.8% | +23.6% | +41.1% |
| Gross Profit | $3.69B | $2.30B | $1.79B | $1.50B | $1.20B |
| Gross Margin % | 82.4% | 80.3% | 80.6% | 78.6% | 78.0% |
| Research & Development (R&D) | $557.7M | $507.9M | $404.6M | $359.7M | $387.5M |
| Operating Income (EBIT) | $1.41B | $310.4M | $120.0M | -$161.2M | -$411.0M |
| Operating Margin % | 31.6% | 10.8% | 5.4% | -8.5% | -26.7% |
| Net Income (GAAP) | $1.63B | $462.2M | $209.8M | -$373.7M | -$520.4M |
| EBITDA (Normalized) | $1.44B | $342.0M | $153.3M | -$138.7M | -$396.1M |
| Diluted EPS ($/sh) | $0.63 | $0.19 | $0.09 | $-0.18 | $-0.27 |
| Operating Cash Flow (OCF) | $2.13B | $1.15B | $712.2M | $223.7M | $333.9M |
| Capital Expenditures (CapEx) | $33.9M | $12.6M | $15.1M | $40.0M | $12.6M |
| Free Cash Flow (FCF) | $2.10B | $1.14B | $697.1M | $183.7M | $321.2M |
| FCF Margin % | 46.9% | 39.8% | 31.3% | 9.6% | 20.8% |
| Return on Invested Capital (ROIC %) | 18.7% | 8.4% | 3.6% | -14.2% | -40.5% |
| Cash & Short-Term Equivalents | $1.42B | $2.10B | $831.0M | $2.60B | $2.29B |
| Total Debt (Short + Long Term) | — | — | — | — | $0 |
| Total Stockholders' Equity | $7.39B | $5.00B | $3.48B | $2.57B | $2.29B |
| LINE ITEM (USD / %) | Q2 2026
FILED 2026-08-04 | Q1 2026
FILED 2026-05-05 | Q4 2025
FILED 2026-02-17 | Q3 2025
FILED 2025-11-04 | Q2 2025
FILED 2026-08-04 | Q1 2025
FILED 2026-05-05 |
|---|---|---|---|---|---|---|
| Revenue (Total Sales) | $1.94B | $1.63B | $1.41B | $1.18B | $1.00B | $883.9M |
| YoY Revenue Growth % | +92.8% | +84.7% | +70.0% | +62.8% | +48.0% | +39.3% |
| Gross Profit | $1.64B | $1.42B | $1.19B | $973.8M | $810.8M | $710.9M |
| Gross Margin % | 84.7% | 86.8% | 84.7% | 82.5% | 80.8% | 80.4% |
| Research & Development (R&D) | $192.5M | $161.0M | $143.6M | $144.2M | $135.0M | $134.9M |
| Operating Income (EBIT) | $912.0M | $754.0M | $575.4M | $393.3M | $269.3M | $176.0M |
| Operating Margin % | 47.1% | 46.2% | 40.9% | 33.3% | 26.8% | 19.9% |
| Net Income (GAAP) | $1.06B | $870.5M | $608.7M | $475.6M | $326.7M | $214.0M |
| EBITDA (Normalized) | $1.00B | $760.8M | $632.9M | $398.1M | $274.7M | $182.7M |
| Diluted EPS ($/sh) | $0.41 | $0.34 | $0.24 | $0.18 | $0.13 | $0.08 |
| Operating Cash Flow (OCF) | $1.22B | $899.2M | $777.3M | $507.7M | $539.3M | $310.3M |
| Capital Expenditures (CapEx) | $14.6M | $7.4M | $13.3M | $6.8M | $7.6M | $6.2M |
| Free Cash Flow (FCF) | $1.20B | $891.8M | $764.0M | $500.9M | $531.6M | $304.1M |
| FCF Margin % | 62.1% | 54.6% | 54.3% | 42.4% | 53.0% | 34.4% |
| Return on Invested Capital (ROIC %) | 37.2% | 38.7% | 30.5% | 25.0% | 17.0% | 12.6% |
| Cash & Short-Term Equivalents | $2.03B | $2.29B | $1.42B | $1.62B | $929.5M | $993.5M |
| Total Debt (Short + Long Term) | — | — | — | — | — | — |
| Total Stockholders' Equity | $9.77B | $8.45B | $7.39B | $6.59B | $5.93B | $5.42B |